Literature DB >> 2809265

Allopurinol for treatment of visceral leishmaniasis in patients with AIDS.

P Dellamonica, E Bernard, Y Le Fichoux, S Politano, M Carles, J Durand, V Mondain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2809265     DOI： 10.1093/infdis/160.5.904

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

Review 1.  Opportunistic protozoan infections in human immunodeficiency virus disease: review highlighting diagnostic and therapeutic aspects.

Authors:  A Curry; A J Turner; S Lucas
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

2.  The need for new therapeutic approaches in visceral leishmaniasis during HIV infection.

Authors:  A Lafeuillade; R Quilichini; C Dhiver; C Mary; J A Gastaut
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 3.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.

Authors:  M Chen; S B Christensen; J Blom; E Lemmich; L Nadelmann; K Fich; T G Theander; A Kharazmi
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

5.  Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani.

Authors:  M Chen; S B Christensen; T G Theander; A Kharazmi
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.